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Actinobacteria of the genus *Nocardia* are often found to be human and animal pathogens that cause pulmonary, cutaneous and subcutaneous diseases ([@B1][@B2][@B3]). However, species in this genus also produce a plethora of potent bioactive natural compounds with therapeutic potential. For example, *Nocardia terpenica* IFM 0406 (formerly referred to as *Nocardia brasiliensis* IFM 0406) is known to produce the antifungal and immunosuppressant brasilinolides A--C ([@B4], [@B5]) and brasilicardins A−D ([@B6][@B7][@B9]). The immunosuppressant brasilicardin A is of particular interest because its potency is superior to today's standard immunosuppressive drugs for organ transplantation, but it is less toxic, since it mediates its activity by a different mode of action ([@B10]). The development of this promising lead structure is currently hampered due to supply issues. The producer strain only shows a low production titer and is furthermore categorized as a biosafety-level 2 organism. Both of these facts make the fermentative production of brasilicardin A expensive and elaborate. Due to its complex stereochemistry, a total synthesis has not been achieved to date ([@B11][@B12][@B13]). Therefore, we want to overcome this hurdle by heterologous expression of the corresponding biosynthetic gene cluster ([@B14]) in a nonpathogenic producer strain. In order to obtain the full biosynthetic pathway, including the related precursor metabolic pathways, we sequenced the genome of *N. terpenica* IFM 0406.

Genome sequencing was carried out using the Illumina HiSeq 2500 and Pacific Biosciences RS II sequencing platforms. Genomic DNA was isolated (ZR fungal/bacterial DNA mini prep kit, Zymo Research) and a paired-end library with bar coding was constructed (Nextera DNA sample preparation kit). The HiSeq paired-end data were processed and filtered, and a quality analysis was performed. This resulted in 6,564,821 reads with an average length of 509 bp (approx. 360× coverage). The quality of the Illumina FASTQ sequences was enhanced by trimming off low-quality bases, which was followed by *de novo* assembly using CLC Genomics Workbench version 7.0.4 to yield contigs. The optimal *k*-mer size was determined using KmerGenie ([@B15]). In addition, a 10-kb genomic sublibrary of strain IFM 0406 was produced and sequenced with PacBioSMRT technology. The resultant continuous long-read (CLR) data were filtered using the SMRT Analysis software suite. In summary, one run produced 113,652 filtered reads with average read lengths of 3,262 bp (approx. 40× coverage). The contigs were linked and placed into super-scaffolds based on the alignment of the PacBio CLR reads using BLASR ([@B16]) and SSPACE-LongRead scaffolder version 7.0.4 ([@B17]). The gapped regions within the super-scaffolds were closed using GapFiller version 1.10 ([@B18]).

The final gap-closed genome comprises three scaffolds with a total size of 9,276,856 bp and a G+C content of 68.5%. The genome contains 8,755 open reading frames, including 76 tRNA genes and nine rRNA operons. Bioinformatic analyses using antiSMASH version 3.0 ([@B19]) revealed that IFM 0406 possessed, besides the putative brasilicardin ([@B14]) and brasilinolide ([@B20]) gene cluster, 47 further orphan natural product biosynthesis gene clusters. Insight into the genome of strain IFM 0406 not only reveals a high potential to produce secondary metabolites, but will also enable and facilitate the heterologous expression and biotechnological production of brasilicardins in a nonpathogenic host system.
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This genome sequence has been deposited in EMBL/GenBank under the accession number [LWGR00000000](https://www.ncbi.nlm.nih.gov/nuccore/LWGR00000000). The version described in this paper is the first version.
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